Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Money-losing companies that went public in 2018 did better than profitable ones

That says more about the market than the companies.

An illustration depicting dollar signs and a city skyline.
An illustration depicting dollar signs and a city skyline.
Javier Zarracina/Vox
Rani Molla
Rani Molla was a senior correspondent at Vox and has been focusing her reporting on the future of work. She has covered business and technology for more than a decade — often in charts — including at Bloomberg and the Wall Street Journal.

Public investors are doing something counterintuitive: They’re valuing unprofitable companies higher than they are profitable ones that entered public stock exchanges last year. Those are the findings from a new PitchBook report on the stock performance of US unicorns.

The study looked at the median stock-price change for startups valued at more than a billion dollars when they went public.

For the unprofitable* ones that went public in 2018, their median stock-price growth has been 120 percent on an annualized basis, from the IPO offering price through March 12 of this year. The median decline for stocks that were profitable has been 57 percent for 2018.

DocuSign, for example, has been consistently unprofitable before and after its April 2018 IPO. It’s currently trading at about $57, well above its $29 offer price.**

In general over the past nine years, profitability has barely made a difference for performance.

A couple big caveats here: Only a couple of the 20 US unicorns that went public last year were profitable, so the sample size is very small. Also, since this data is looking at compound annual growth rates, big jumps or dives in price for first-year stocks will look more inflated than they will likely be over time. Still, the money-losing companies that dominate the sample are doing relatively well enough to show there’s a definite public appetite for them.

“In general, you’re not seeing a huge preference either way in public markets for if a company has been profitable or unprofitable at its IPO,” Cameron Stanfill, an analyst at PitchBook and the report’s author, told Recode.

That says more about the market than the companies and means that investors are prizing future growth over present profitability.

“They believe in the business model and are disregarding the current state of profitability at the IPO,” Stanfill said.

That’s the same as with some private investors and venture capitalists, who are taking these companies public in the first place. Indeed, unprofitable companies are going public at a record rate, one not seen since the dot-com bubble.

Of course, the dot-com bubble did eventually burst, so it’s difficult not to see this latest round of unprofitable IPOs as grim tidings.

However, there are a few stark differences.

Many unprofitable companies could be profitable if they switched their focus from growth to profit. Spotify has long said it could be profitable if it weren’t trying to grow. It recently became profitable for the first time, less than a year after it was listed on the stock market. Lyft — for a 2019 example — could have had a positive net last year if it didn’t spend any money on advertising or R&D. Not spending that money, however, would stop it from gaining more customers. It would also stunt the company’s dream of developing a future of driverless cars, a plan that could see Lyft taking a bigger cut of revenue.

The companies that are going public lately — basically all of which are tech or biotech companies — are also older and have more established revenue streams and business models than their dot-com counterparts. Lyft generated $2.2 billion in revenue last year, a sum unimaginable to the internet companies of the late ’90s.

Still, when a recession hits, likely within the next two years, the crowd will certainly be thinned.

“Those that are profitable will potentially be in a better position,” Stanfill said. “A company is more defensible in downturn if it’s making a profit.”

* PitchBook is looking at IPO profitability using Ebitda margins, which add back in interest, taxes, depreciation, and amortization. True profit would be lower.

** These price changes are from the offering price through March 12, 2019. The offering price is the usually lower price institutional investors buy stock at right before it’s traded on the public market.

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh